Co-amoxiclav side effects: common, serious and urgent symptoms
What co-amoxiclav is and why side effects happen
Co-amoxiclav is a prescription antibiotic that combines amoxicillin, a penicillin antibiotic, with clavulanic acid, a beta-lactamase inhibitor. It is used for certain bacterial infections. It does not treat viral infections such as colds or flu.
This article uses 'co-amoxiclav' to refer to co-amoxiclav and equivalent amoxicillin/clavulanate products. Depending on the country, it may be supplied under different brand names and in different formulations, commonly including tablets or an oral liquid. The patient leaflet or official medication information that comes with your specific product is the best place to check formulation-specific instructions and warnings.
Side effects can happen because antibiotics affect the body as well as the bacteria they are intended to treat. With co-amoxiclav, reported side effects can involve the digestive system, skin, immune system, liver, and bowel. A symptom that appears during treatment is not automatically caused by the medicine, but timing can be important, especially when symptoms are severe, unusual, or getting worse.
Most side effects people notice are digestive and are often manageable. Others, such as breathing difficulty, swelling of the face or throat, blistering skin, severe watery or bloody diarrhea, or signs of liver trouble, need urgent medical assessment.
Common digestive side effects
The most commonly reported co-amoxiclav side effects are digestive symptoms: diarrhea, nausea, vomiting, and stomach upset. These symptoms can be unpleasant, but mild nausea or diarrhea does not by itself prove that a serious complication is happening.
Taking co-amoxiclav with a meal or snack is described in patient medication information as a way to help reduce stomach upset. This may make the medicine easier to tolerate, but it is not a guarantee that digestive side effects will not occur. Follow the instructions given with your own product or by your prescriber or pharmacist.
Ordinary mild digestive upset is different from warning signs such as diarrhea that is persistent, very watery, or bloody, especially if it comes with abdominal pain, cramps, or fever. Those symptoms may suggest a more serious antibiotic-associated bowel problem and should be treated as a reason to seek medical advice rather than as routine stomach upset.
If diarrhea is significant, severe, or accompanied by warning signs, do not self-treat with an antidiarrheal medicine without checking with a healthcare professional. Side effects that are severe, bothersome, or do not go away should be discussed with a pharmacist or doctor.
Co-amoxiclav: Recognizing serious side effects
Thrush, rashes and other less serious effects
Thrush, vaginal itching, and vaginal discharge are reported with amoxicillin/clavulanate products. Antibiotics can disrupt normal microorganisms in the body, which may contribute to symptoms such as thrush, although symptoms should not be self-diagnosed solely on that basis. A pharmacist or clinician can help decide whether symptoms are likely to be related and what treatment, if any, is appropriate.
A rash can be more difficult to judge. Some rashes are less serious, but a new rash during co-amoxiclav treatment should not automatically be dismissed as harmless. Hives or an itchy rash can be part of an allergic reaction, especially if other symptoms are present.
Local irritation or mild symptoms are different from warning signs such as swelling of the face, lips, tongue, or throat; wheezing; trouble breathing or swallowing; blistering or peeling skin; sores in the mouth or other mucous membranes; fever; or a widespread severe rash. Those symptoms need urgent or emergency medical attention depending on severity.
If a breastfeeding parent is taking co-amoxiclav, some breastfed babies may develop diarrhea, oral thrush, a rash, reduced feeding, irritability, or unusual sleepiness. Professional advice is appropriate if these symptoms occur.
Serious allergic and skin reactions
Serious allergic reactions can develop with co-amoxiclav and need immediate attention. Warning signs include hives or a widespread itchy rash, swelling of the face, lips, tongue, or throat, wheezing, and difficulty breathing or swallowing. Swelling that affects the airway, breathing problems, or trouble swallowing is an emergency; seek emergency medical help rather than waiting for a routine appointment.
Skin symptoms can also signal a serious reaction. Blistering, peeling, or shedding skin; sores on mucosal surfaces such as the mouth; fever with a rash; or a widespread severe rash require urgent medical assessment. These symptoms can be signs of severe cutaneous reactions and should not be managed by simply watching and waiting at home.
Do not try to diagnose the exact reaction yourself or decide on your own to restart, substitute, or change the antibiotic. The immediate priority is appropriate medical assessment. If symptoms suggest anaphylaxis or airway involvement, use emergency services. If the reaction is severe but not immediately life-threatening, seek urgent clinical advice promptly and have the medicine packaging available if possible.
Liver problems and severe bowel complications
Possible liver-problem warning signs during or after co-amoxiclav treatment include yellowing of the skin or eyes, dark urine, light or pale stools, unusual tiredness, reduced appetite, nausea, or pain or discomfort in the upper right side of the abdomen. These symptoms need prompt medical advice because they are not typical mild stomach upset.
Severe antibiotic-associated bowel symptoms are also different from ordinary mild diarrhea. Warning signs include persistent or very watery diarrhea, bloody stools, abdominal pain or cramps, and fever. A complication such as C. difficile-associated diarrhea can occur during antibiotic treatment or after antibiotics have ended, so new severe bowel symptoms remain relevant even if the course is finished. These symptoms do not prove a specific diagnosis, but they do require medical assessment.
Severe vomiting soon after taking a dose is also listed in medication information as a serious symptom that warrants prompt medical attention. This is not a rule for diagnosing a particular problem, but it is a reason to contact a healthcare professional urgently.
If severe diarrhea, blood in the stool, fever, significant abdominal pain, jaundice, dark urine, pale stools, or other concerning symptoms occur, seek medical advice promptly rather than treating the episode as routine digestive upset.
Medicines and health conditions requiring extra caution
Before taking co-amoxiclav, tell the prescriber or pharmacist if you have had an allergy to co-amoxiclav, amoxicillin, penicillin, or other antibiotics. Also mention any previous liver problems or jaundice after taking antibiotics, current kidney or liver disease, or mononucleosis or suspected glandular fever.
Medication review matters because some medicines and products may require extra caution or monitoring. Important items to disclose include warfarin, allopurinol, probenecid, methotrexate, and any other prescription or non-prescription medicines. Vitamins, supplements, and herbal remedies should also be mentioned, because they are part of the safety picture even when they are not prescribed.
Do not start, stop, or alter other medicines because of possible interactions without professional advice. Co-amoxiclav safety considerations depend on the individual, the infection being treated, the formulation, and the other medicines being used.
Pregnancy and breastfeeding should be discussed with a doctor or pharmacist. Official NHS information states that co-amoxiclav can usually be used in pregnancy when clinically needed and while breastfeeding, but individual advice is still required. If a breastfed baby develops diarrhea, oral thrush, rash, reduced feeding, irritability, or unusual sleepiness while the parent is taking co-amoxiclav, seek professional advice.
What to do about side effects and when to seek help
For mild nausea, mild stomach upset, or mild diarrhea, follow the product instructions and ask a pharmacist or doctor if symptoms are troublesome, severe, or do not go away. Taking co-amoxiclav with a meal or snack may help reduce stomach upset, but persistent or worsening symptoms should not be ignored.
Seek emergency help right away for breathing difficulty, wheezing, trouble swallowing, or swelling of the face, lips, tongue, or throat. Urgent medical assessment is also needed for blistering or peeling skin, sores on mucous membranes, fever with a severe rash, yellowing of the skin or eyes, dark urine, pale stools, severe or very watery diarrhea, bloody stools, severe abdominal pain or cramps, or fever with bowel symptoms.
Do not stop, restart, substitute, or change how you take co-amoxiclav without medical direction. If emergency symptoms occur, getting urgent care takes priority over routine medicine-taking advice.
If you miss a dose, the NHS advises taking it when remembered unless it is nearly time for the next dose. In that case, skip the missed dose, wait at least four hours between doses, and do not take two doses to make up for one you missed.
When seeking help, have the medicine packaging, dosing instructions, and a list of your other medicines, supplements, and herbal products available.
Reporting side effects and checking product information
Suspected co-amoxiclav side effects can be reported through the medicine safety reporting system in the relevant country. In the UK, suspected side effects can be reported through the Yellow Card scheme. In the US, suspected adverse effects can be reported to the FDA MedWatch program. Reporting routes are country-specific, so people outside these systems should use their local medicines regulator or ask a pharmacist how to report.
Reporting a side effect does not replace medical treatment. If symptoms suggest a serious allergic reaction, severe skin reaction, liver problem, or severe bowel complication, seek urgent or emergency medical care first. A side-effect report also does not prove that co-amoxiclav caused the symptom; it helps regulators monitor possible medicine safety issues.
The patient leaflet or official medication information supplied with your co-amoxiclav product should be checked for the full list of possible side effects, warnings, and instructions. This article highlights common effects and key warning symptoms, but it is not an exhaustive adverse-effect catalogue.
Co-amoxiclav is a prescription antibiotic combining amoxicillin and clavulanic acid, used for bacterial infections but not viral ones like colds or flu. Common side effects are digestive (diarrhea, nausea, vomiting, stomach upset), often mild and sometimes reduced by taking the medicine with food, but persistent, watery, or bloody diarrhea-especially with abdominal pain or fever-signals a more serious antibiotic-associated bowel problem requiring medical assessment rather than self-treatment.
Serious allergic reactions can cause hives, swelling of the face/lips/tongue/throat, wheezing, or difficulty breathing/swallowing and require immediate emergency care. Skin symptoms such as blistering, peeling, mucosal sores, or fever with a widespread rash may indicate severe cutaneous reactions needing urgent attention. Liver-problem warning signs include yellowing of the skin or eyes, dark urine, pale stools, unusual tiredness, or upper right abdominal pain, which also need prompt medical advice. Severe vomiting after a dose, or new severe bowel symptoms even after finishing the course, warrant urgent professional assessment.
Before taking co-amoxiclav, disclose any antibiotic allergies, prior liver issues, kidney or liver disease, mononucleosis, and all current medicines including vitamins and supplements. Pregnancy and breastfeeding are usually possible when clinically needed, but individual advice is required; if a breastfed baby develops diarrhea, thrush, rash, reduced feeding, irritability, or unusual sleepiness, professional advice is appropriate.
Publishing organization: National Institute for Health and Care Excellence
Publishing organization: Medicines and Healthcare products Regulatory Agency
Publishing organization: U.S. National Library of Medicine
Questions and comments
Please do not include passwords, medical record numbers, insurance information, financial information, precise addresses, or other confidential or directly identifying information in your message.